Recent Headlines
Within Biotechnology
Sustainable Now Technologies Appoint Chief Operations Officer
Algae Bio-Reactor Manufacturer, Sustainable Now Technologies, officially recognizes Nathan Morrison as Chief of Operations. - June 27, 2009 - Sustainable Now Technologies
AnaSpec Introduces New SensoLyte® LSD1 Assay Kit
AnaSpec has announced the release of a new long wavelength assay for Lysine-Specific Demethylase –1 (LSD1), the SensoLyte® LSD1 Assay Kit, Ex/Em=530/590 nm. LSD1 is a histone-modifying enzyme catalyzing lysine demethylation of histone H3. It plays an important role in regulation of gene... - June 25, 2009 - AnaSpec, EGT Group
Dentists Are Throwing Away the Cling Film and Switching to SteriTouch Keyboard Covers
Recognising the risk of cross contamination, Dentists have often used rolls of cling film to cover their keyboards...both awkward and time consuming. The cling film is now being swapped for permanent covers which not only allow the keyboard to be cleaned and decontaminated in-situ, but also prevent bacterial and fungal growth in between cleaning cycles. - June 25, 2009 - SteriTouch Ltd
Nanion and Axiogenesis Present Parallel Patch Clamp Recordings of Action Potentials from Cor.At Cardiomyocytes
Stem cell derived cardiomyocytes were analyzed using Nanion’s automated patch clamp systems, the Patchliner and the Port-a-Patch to validate ion channel composition, the presence of action potentials and the effect of compounds on cardiac ion channels. - June 25, 2009 - Nanion Technologies GmbH
Nanomi Joins Consortium to Address Chronic Kidney Disease
Nanomi, a leading provider of microsphere-based drug delivery technologies to the pharmaceutical industry, announced today that it joined a consortium for the development of a therapy to prevent chronic kidney disease. In an aging population, the worldwide incidence of chronic kidney disease,... - June 25, 2009 - Nanomi
AnaSpec Introduces Fluorescent GO™ Peptides
Fluorescent peptides, peptides with a reporter fluorescent dye, are valuable probes used in visualizing intracellular processes and molecular interactions at the level of single cells.1 The fluorescent dye can be attached to the amino (N) or carboxy (C)-terminus, or in the case of FRET... - June 23, 2009 - AnaSpec, EGT Group
MicroTransponder Awarded "Most Promising Life Science Technology Company - 2009" at Rice Alliance Venture Forum
MicroTransponder awarded “Most Promising Life Science Technology Company - 2009” at Rice Alliance Venture Forum and announces executive promotions of Jordan Curnes to President and Frank McEachern to Chairman of the Board. Rosellini will be interviewed on the BusinessMakers radio show this Saturday, June 20. The interview will be available on their website www.thebusinessmakers.com. - June 18, 2009 - MicroTransponder Inc.
Baxa Corporation Releases IntelliFlowRx™ Upgrades
New release of Baxa Corporation’s IntelliFlowRx workflow management system provides significant operational enhancements and new capabilities. IntelliFlowRx is designed to improve safety and accuracy in pharmacy-based IV admixture preparation. The system also streamlines compliance with sterile preparation regulatory steps while improving visibility to and oversight of IV room operations. - June 18, 2009 - Baxa Corporation
Anavex Appoints Dr. Hervé De Kergrohen as CEO to Lead Company Through Clinical Trials and Future Growth
Anavex Life Sciences Corp., (“ANAVEX”) (OTCBB: AVXL) today announced the immediate appointment of Hervé de Kergrohen, MD, MBA, as its Chief Executive Officer (CEO) and director. Dr. de Kergrohen is an accomplished senior executive who has successfully founded and developed... - June 18, 2009 - Anavex Life Sciences Corp.
Sustainable Now Technologies Incorporates
Sustainable Now Technologies, an alternative energies technology manufacturer, announced today the news of the company’s official incorporation. - June 10, 2009 - Sustainable Now Technologies
ENCO Pharmaceutical Development Announces Addition of Keith Hurley as Vice-President of Sales and Marketing
ENCO Pharmaceutical Development, Inc. is pleased to announce the addition of Mr. Keith Hurley to its staff as Vice-President of Sales and Marketing. - June 06, 2009 - Enco Pharmaceutical Development, Inc.
Merrion Pharmaceuticals Announces Positive Phase IIB Study for Orazol Tablet Form of Zoledronate IV Infusion at ASCO Annual Meeting
Weekly tablet delivers major new benefits for patients, doctors and payors: avoiding the need for burdensome and costly infusions and related infection risks; weekly tablet dosing offers potential for better safety and side effect profile of a ‘gold standard’ oncology drug. - June 06, 2009 - Merrion Pharmaceuticals
AnaSpec Signs Distribution Agreement with Bioeksma UAB
AnaSpec, Inc. and Bioeksma UAB today announced a non-exclusive distributor agreement that will allow Bioeksma UAB to distribute AnaSpec’s catalog and custom products throughout Lithuania and Latvia. AnaSpec’s Director of Sales & Marketing, Violeta Rajkovska, noted, “AnaSpec... - June 05, 2009 - AnaSpec, EGT Group
Colorado BioScience Association Applauds Governor Bill Ritter’s Signing of House Bills 1035 and 1105, Ensuring Colorado’s Position as a Thriving Location for Bioscience
Colorado Governor Bill Ritter has signed HB 1035 (expanding sales and use tax for medical device companies) and HB 1105 (Angel Investment Tax Credit), ensuring Colorado’s position as a thriving location for bioscience and emerging technology companies. The announcement is made by John Collar,... - June 04, 2009 - Colorado BioScience Association
RayBiotech Now Offers Nearly 500 ELISA Kits
RayBiotech, the Protein Array Pioneer Company, has just increased its product line of different ELISA kits to 495, including ones detecting cytokines, chemokines, growth factors, angiogenic factors and adipokines in human, mouse, and rat samples. - June 03, 2009 - RayBiotech, Inc
Clinical Trials in Russia. 1st Quarter 2009
On June 01, 2009 Synergy Research Group (SynRG), a Russia-based CRO, presented the English version of SynRG Orange Paper Q1 2009, a regular analytical report on the clinical trial market in Russia. The report is Free and contains hundreds of figures as well as dozens of tables and pictures covering various aspects of the Russian clinical trial market. - June 03, 2009 - Synergy Research Group
Advanced Biotechnologies, Inc. (ABI) Adds UV-Inactivated Purified Whole Virus Product to Aid in Research of Human Influenza
ABI adds (H2N2) Purified Whole Virus, UV-Inactivated for use in H2N2 subtype-specific protein-based testing. Catalog # 10-126-000 - June 01, 2009 - Advanced Biotechnologies, Inc.
Bioo Scientific’s Toxicity Assay Kits Increase the Efficiency of Drug Development
Bioo Scientific announced the launch of the MaxDiscovery™ Toxicity Assay Kits for the monitoring of toxic effects in in vivo preclinical studies. - May 31, 2009 - Bioo Scientific
AnaSpec Introduces Industry’s First FRET-Based Thrombin Assay Kit
AnaSpec has announced the launch of the industry’s first FRET-based thrombin assay – the SensoLyte 520 Thrombin Activity Assay Kit. Thrombin, a serine protease, plays a central role in hemostasis by converting soluble plasma fibrinogen into an insoluble fibrin clot and by promoting... - May 30, 2009 - AnaSpec, EGT Group
Advanced Biotechnologies, Inc. (ABI) Adds Cytomegalovirus (CMV) β-PL Inactivated Purified Whole Virus Product
Cytomegalovirus (CMV) AD169, Purified Whole Virus was inactivated by treatment with Beta-propiolactone (β-PL). β-PL is a DNA alkylating agent that has been shown to be effective in the inactivation of a virus. It chemically modifes viral DNA without affecting the immunogenicity or protein... - May 30, 2009 - Advanced Biotechnologies, Inc.
Colorado Again Confirmed as Top Bioscience State by National Rankings & Venture Capital Funding Activity
It’s been another outstanding year for Colorado in the highly competitive state rankings arena. FierceBiotech included Colorado in its top five regions targeting biotech companies. Further, Colorado now ranks 8th in VC funding for biotech firms and 10th for medical device and equipment firms, as recently reported by Genome Technology. Colorado’s venture capital success was vividly demonstrated when Boulder-based Clovis recently launched with an impressive $145 million in start-up funding. - May 29, 2009 - Colorado BioScience Association
IonSense to Present Simplified DART Source with iPod Control at the American Society for Mass Spectrometry Annual Conference
Enables Direct Analysis of Gas, Liquids and Solids in Seconds - May 28, 2009 - IonSense, Inc.
Innoget Launches a New Open Innovation Portal
· Web 2.0 linking companies to the scientific community · Awarded by the Barcelona County Council as the best entrepreneur Project in the year 2008 · Red Innovation Center - Vodafone Spain, Grupo Damm, Affinity Petcare, Indo, Fluidra, Bicentury, Oryzon Genomics, the first companies to use it - May 23, 2009 - innoget
"Stress Free Nation" Campaign from Indigene Initiated in Bahrain
“Stress Free Nation” Campaign from Indigene is designed for Pharmacists and consumers and will educate them about the ways to manage high stress levels. - May 22, 2009 - Indigene Pharmaceuticals
Techno-Derm’s New PhysioRed Technology Lights Up Fitness Centers and Dayspas Across the Nation
Techno-Derm has just launched PhysioRed, a new, FDA-listed fitness device that combines reclined exercise with infrared light for body detox, weight loss, muscle toning, skin beautification, cardio health and overall wellness. - May 21, 2009 - Techno-Derm, LLC
AnaSpec Introduces Line of Membrane Potential Fluorescent Probes
AnaSpec has introduced a wide selection of membrane potential fluorescent probes. The plasma membrane of a cell typically has a transmembrane potential of approximately -70 mV (negative inside) as a consequence of K+, Na+ and Cl– concentration gradients that are maintained by active... - May 20, 2009 - AnaSpec, EGT Group
MedSource Awarded Services Contract for a Phase I Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia Clinical Trial
Houston-based Contract Research Organization (CRO) to manage three-year Phase I study - May 17, 2009 - MedSource
Red Cedar Technology Releases HEEDS Professional 5.3
New interfaces for LS-DYNA and Abaqus streamline the optimization process for engineers. - May 16, 2009 - Red Cedar Technology
MedSource Awarded Services Contract for a Phase III Epilepsy Clinical Trial
MedSource, a Contract Research Organization (CRO) providing Phase I-IV clinical trials support, announced it has been awarded a service contract to manage a 50-center, multi-national, late phase epilepsy trial. The Houston-based CRO with regional offices in Raleigh, NC, will provide Project... - May 15, 2009 - MedSource
AnaSpec Introduces Biotin Labeled Beta-Amyloid GO™ Peptides
AnaSpec has introduced a line of b-amyloid peptides labeled with biotin (N or C-terminal biotin labels) as well as N-terminal biotin labeled b-amyloid peptides with a fluorescein label on the C-terminus. - May 15, 2009 - AnaSpec, EGT Group
Sustainable Now Technologies Appoints Chief Technology Officer
At a recent press conference, Sustainable Now Technologies (SNT) announced the appointment of their third officer. - May 15, 2009 - Sustainable Now Technologies
Baxa Corporation and CriticalPoint™ Training Rated “Excellent” in Customer Satisfaction
Baxa Corporation and CriticalPoint, LLC, announce positive results for the CriticalPoint training program from the Pharmacy Purchasing and Products 2nd annual national survey. This high level of user satisfaction can be attributed to the program’s simple Internet access, high- written by industry experts and the ease of tracking employee training through its Learning Management System. - May 13, 2009 - Baxa Corporation
Sustainable Now Technologies Launches Website
Green Technologies Corporation, Sustainable Now Technologies (SNT), announces the launch of it's official company website. - May 13, 2009 - Sustainable Now Technologies
AnaSpec Launches Z-Fish™ Antibodies
AnaSpec has announced the launch of the Z-Fish™ product line of antibodies in order to address the growing needs of the research community for zebrafish specific antibodies, peptides and other products. - May 09, 2009 - AnaSpec, EGT Group
Indigene Launches Memoryl in Cyprus
Indigene Pharmaceuticals, A US based bio-pharmaceuticals company, has announced the launch of its highest selling brand Memoryl in Cyprus in association with M S Jacovides group. “We are delighted to launch Memoryl in Cyprus in association with M S Jacovides group and we are sure that our... - May 09, 2009 - Indigene Pharmaceuticals. Pvt. Ltd
Special DNA Testing Offered in Response to Swine Influenza Epidemic
Personal genome company, BioResolve, Inc has introduced a DNA testing service that reveals an individual's innate resistance or vulnerabilities to infectious diseases, such as swine flu. The final report states an individual's ratio of surviving a worldwide pandemic with respect to the average human, and looks into all types of infectious diseases. - May 08, 2009 - BioResolve, Inc.
CodonCode Corporation Announces Free License Program for DNA Sequence Assembly Software
Free licenses for CodonCode Aligner, a leading software program for DNA sequence assembly and analysis, will be made available to selected applicants under CodonCode Corporation's new License Grant Program. - May 07, 2009 - CodonCode Corporation
Bioo Scientific Corp. Receives NIH Grant for the Development of Novel Anti-Viral Therapeutics
Bioo Scientific received a $1.25 million grant from the National Institutes of Health to develop new anti-viral therapeutics. - May 07, 2009 - Bioo Scientific
Chief Technology Officer for Baxa Corporation’s Subsidiary, FHT, Inc., Presents at the Fourth Annual unSUMMIT for Bedside Barcoding in Tampa, Florida
Dennis Tribble, PharmD, will speak on “Upstream Processing of Medications” at this year’s unSUMMIT, May 6-8, at the Tampa Marriott Waterside Hotel and Marina. The presentation describes the infrastructure necessary for a successful Bar Code Medication Administration (BCMA) system and is being held today, Wednesday, May 6, 2009, at 2:20 p.m. Participants are eligible for one contact hour of Pharmacy Continuing Education (CEU). - May 06, 2009 - Baxa Corporation
Functional Genetics Highlights Progress in the Development of Broad-Spectrum Antiviral at the 22nd International Conference on Antiviral Research
Functional Genetics, Inc. today announced that two platform presentations and three poster abstracts on progress being made in its broad-spectrum antiviral programs will be presented during the International Conference on Antiviral Research in Miami, FL from May 4 to 7. “The development of... - May 06, 2009 - Functional Genetics, Inc.
AnaSpec Introduces New SensoLyte Anti-Human MOG (1-125) IgG ELISA Kit
AnaSpec has announced the release of the newest addition to its Anti-MOG ELISA assay kit series – the SensoLyte Anti-Human MOG (1-125) IgG Quantitation ELISA Kit. This kit, along with previously featured SensoLyte Anti-Mouse MOG (1-125) and SensoLyte Anti-Rat MOG (1-125) IgG ELISA assay kits... - May 03, 2009 - AnaSpec, EGT Group
ENCO Analytix, Inc, Announces Name Change to ENCO Pharmaceutical Development, Inc.
ENCO Analytix, Inc. announced today that effective immediately the company name will change to ENCO Pharmaceutical Development, Inc. - May 03, 2009 - Enco Pharmaceutical Development, Inc.
Bioo Scientific Launches In Vivo siRNA Delivery Reagent
Bioo Scientific Developed MaxSuppressor In Vivo RNA-LANCEr II to Optimize in vivo RNAi. - May 01, 2009 - Bioo Scientific
AnaSpec Launches New Headquarters in Fremont, California
Today AnaSpec announced the launch of its new headquarters in Fremont, California. Rapidly expanding over the past 16 years, AnaSpec has graduated to a state-of-the-art facility designed from the ground up for the very highest levels of lab and R&D production. The 44,010 square foot facility... - April 30, 2009 - AnaSpec, EGT Group
New Scientific Publication Explains How LDB B-30892 Inhibits the Cytotoxic Effects of Clostridium difficile
LacPro Industries LLC, a probiotic-based biotherapeutics company, announces a publication in the peer-reviewed scientific journal, Gut Pathogens, entitled, "Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells.” In this scientific publication, the research team explains the published in vitro research demonstrating the beneficial effect of LacPro's proprietary probiotic strain. - April 28, 2009 - LacPro Industries LLC
Strand Life Sciences Solution for Bioinformatics Challenges in NGS
New software solution for the analysis of data from Next-Generation Sequencing (NGS) experiments. - April 28, 2009 - Strand Life Sciences Pvt. Ltd.
Baxa Corporation Wins Two 2009 Colorado BMA Gold Key Awards
Baxa Corporation campaigns awarded 2009 Business Marketing Association Gold Key Awards for Product Literature and Websites/Search Engine Marketing. The BMA Gold Key Awards are one of Colorado’s most highly acclaimed marketing competitions, with entries reviewed by a panel of six independent judges from across the US. - April 27, 2009 - Baxa Corporation
Colorado BioScience Association Names Rick Jory Board Chair, Announces 2009 Sponsors and Appoints Seven New Board Members
Rick Jory, CEO of Sandhill Scientific, Inc., Highlands Ranch, was named chairperson of the board of directors for the Colorado BioScience Association (CBSA). He was appointed at the association’s 2009 annual meeting yesterday. Jory assumes chairperson responsibilities from Jack Wheeler, MicroPhage, Inc. In other action, seven new members were named to the CBSA board of directors. - April 23, 2009 - Colorado BioScience Association
LacPro Industries, LLC Named Techpoint Mira Award Finalist
Fort Wayne-based LacPro, a biotherapeutic company developing a product for Clostridium difficile Infection, has been named a finalist for Innovation of the Year. - April 22, 2009 - LacPro Industries LLC
Baxa ‘Ecological’ Program Promotes Benefits of Recycling
Commitment to ‘green’ activities at Baxa Corporation celebrates Earth Day 2009 while providing reduced costs and workplace benefits. Historically, Baxa has chosen product designs and raw materials that reduce waste and improve patient safety and minimize environmental impact. More recently, the company has introduced specific initiatives for reducing its environmental impact and advancing its environmental stewardship. - April 20, 2009 - Baxa Corporation